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ABSTRACT
Crocus sativus, known as saffron, is used in folk medicine for treatment of different types of diseases, and its
anti-inflammatory and free radical scavenging activities have been demonstrated. The present study evaluated
gentamicin nephrotoxicity in saffron treated rats.
Male Wistar rats (200-250g) were treated with saffron (40 or 80 mg/k/d) for 10 days, or saffron (40 or 80 mg/
kg/d) for 10 days and gentamicin 80 mg/kg/d for five days, starting from day 6. At the end of treatment, blood
samples were taken for measurement of serum creatinine (SCr) and BUN. The left kidney was prepared for
histological evaluation and the right kidney for Malondialdehyde (MDA) measurement.
Gentamicin 80 (mg/k/d) increased SCr, BUN and renal tissue levels of MDA and induced severe histological
changes. Saffron at 40 mg/k/d significantly reduced gentamicin-induced increases in BUN and histological
scores (p<0.05). Gentamicin-induced increases in BUN, SCr and MDA and histological injury were
significantly reduced by treatment with saffron 80 mg/k/d (p<0.05, p<0.001, p<0.05, and p<0.001
respectively). In conclusion, our results suggest that saffron treatment reduces gentamicin-induced
nephrotoxicity and this effect seems to be dose dependent.
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INTRODUCTION
Aminoglycosides, such as gentamicin, are a
class of clinically important antibiotics used
extensively in the treatment of infections,
particularly against aerobic gram-negative
bacteria (Nagai and Takano, 2004).
However, nephrotoxicity and ototoxicity
there are serious side effects in the use of
aminoglycosides. The toxicity of
gentamicin, the most widely used drug in
this category, is believed to be related to
the generation of reactive oxygen species
(ROS) in the kidney (Baliga et al., 1999;
Martínez-Salgado et al. ,  2002). ROS
induces vasoconstriction and decreases
glomerular filtration rate (GFR). ROS also
induces cellular injury and necrosis via
lipid peroxidation and protein modification
(Edson and Terrell, 1999). Most of the
intravenously administered dose is excreted
in the urine, whereas some of the
aminoglycoside injected is selectively
accumulated in the renal cortex (Nagai and
Takano, 2004; Konopska and Warwas,
2007) leading to renal cell injury.
Crocus sativus L. (Iridaceae), commonly
known as saffron, is used in folk medicine
for various purposes, such as an aphrodisiac,
antispasmodic and for expectorant effects
(Rios et al., 1996). Modern pharmacological
studies have demonstrated that saffron
extracts have antinociceptive, anti-
inflammatory (Hosseinzadeh and Younesi,
2002), antitumour (Escribano et al., 1996;
Nair et al., 1991; Salomi et al., 1991),
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radical scavenger (Abdullaev, 1993), and
anticonvulsant effects (Hosseinzadeh and
Khosravan, 2002). In addition, it has been
shown that saffron improves learning and
memory (Abe et al., 1999; Zhang et al.,
1994). Chemical studies of C. sativus have
shown the constituents to include crocin,
crocetin, safranal and picrocrocin (Tarantilis
et al., 1995; Escribano et al., 1996; Lozano
et al., 2000). Among these constituents,
crocetin is mainly responsible for
pharmacological activities (Abe et al., 1999).
A recent study demonstrated protective
effects for aqueous saffron extract (Crocus
sativus L.) and its active constituent,
crocin, against renal ischemia reperfusion
induced oxidative injury in rats
(Hosseinzadeh et al., 2005). We then
attempted to develop new strategies for
preventing the nephrotoxicity of
aminoglycosides. The aim of the present
study was to assess the protective effects of
aqueous saffron extract on gentamicin
induced nephrotoxicity in rats.
MATERIALS AND METHODS
Animals
The experimental protocol was approved by
the Ethics Review Committee for Animal
Experimentation of Iran University of
Medical Sciences. Adult male wistar rats
weighing 200-250 g were used. All of them
were kept in the same room under a
constant temperature (22 ±2 oC) and
illuminated 7: 00 a.m. to 7: 00 p.m., with
food pellets and water available ad libitum.
Experimental design
Animals were divided randomly into six
groups, each with 8 rats. Group 1 was the
control group in which animals were only
treated with normal saline for five days,
Group 2 was given gentamicin (Alborz-
Darou Pharmaceutical Co.) 80mg/kg/d (IP)
for five days, Group 3 was given aqueous
saffron extract(40 mg/kg/d) orally for 10
days, Group 4 was given aqueous saffron
extract (80 mg/kg/d) orally for 10 days,
Group 5 was given aqueous saffron extract
(40 mg/kg/d) orally for 10 days and was
given 80 mg/kg/d gentamicin (IP) for five
days starting from day 6, Group 6 was
given aqueous saffron extract (80 mg/kg/d)
orally for 10 days and was given
gentamicin 80 mg/kg/d (IP) for five days
starting from day 6.
After 5 days of treatment with
gentamicin (80 mg/kg/d), control and
experimental animals were anaesthetized
with Xylazine (10 mg/kg/d) and Ketamine
HCl (50 mg/kg/d); Xylazine was purchased
from Chanelle Pharmaceutical Co., Galway,
Ireland and Ketamine HCl from Parke-
Davis Pharmaceutical Co., Cambridge, UK.
Then anaesthetized rats were sacrificed in a
rapid and painless method and blood was
collected and serum samples were separated
by centrifugation and used for measurement
of serum creatinine (SCr) and BUN using a
commercial kit (PA, Tehran, Iran) and
Hitachi multianalyser (Hitachinaka, Japan).
The abdomen was opened and kidneys were
dissected out and the left kidneys were
processed for light microscopic (Olympus-
BH-2) observation, according to standard
procedures. The kidneys were fixed in
phosphate-buffered 10% formalin and then
embedded in paraffin wax, sectioned (4-
5μm) and stained with Hematoxylin and
Eosin (H&E). The right kidneys were
removed and maintained at -80 °C
(Fernandez et al., 1997). On the day of
analysis,  the kidney tissues were
homogenized in cold KCl solution (1.5%)
to give a 10% homogenate suspension and
used for biochemical assays.
MDA measurement
Malondialdehyde (MDA) levels, as an
index of lipid peroxidation, were measured
in renal tissue. MDA, as a thiobarbituric
acid reactive substance (TBARS), reacts
with thiobarbituric acid (TBA) to produce a
red colored complex that has peak
absorbance at 532 nm (Fernandez et al.,
1997). Absorbance was measured in the
visible range using an ELISA plate reader
(Helsinki, Finland).
Phosphoric acid (3 ml; 1%) and TBA (1
ml; 0.6%) were added to 0.5 ml of
homogenate in a centrifuge tube and the
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mixture was heated for 45 min in a boiling
water bath. After cooling, 4 ml of n-butanol
was added to the mixture and vortex-mixed
for 1 min followed by centrifugation at
20000 rpm for 20 min. The organic layer
was transferred to a fresh tube and its
absorbance was measured at 532 nm. The
standard curve of MDA was constructed
over the concentration range of 0-40 μM
(Uchiama and Miahara, 1978).
Determination of renal tissue injury
The severity of the histological lesion
was graded from 0 to 4, by a blindfold
fashion (all slices were evaluated by two
blind-folded pathologists and the results
were collectively introduced in analysis and
explanation), as the following (Jablonski et
al., 1983):
0; no sign of necrosis (no damage), 1+;
necrosis of individual cells, 2+; necrosis of
all cells in adjacent proximal convoluted
tubules, with survival of surrounding
tubules, 3+; necrosis confined to the distal
third of the proximal convoluted tubule
with a band of necrosis extending across the
inner cortex. 4+; necrosis affecting all the
three segments of the proximal convoluted
tubule.
Statistical analysis
Serum Cr and BUN and tissue MDA levels
are presented as Means ± S.E.M. Means of
groups were compared by one-way analysis
of variance (ANOVA) then Post-Hoc
analysis (Tukey test) was performed for
assessing specific group comparisons.
Mann-Whitney U test was used for
comparison of histological data. The level
of statistical significance was accepted as p
<0.05. Calculations were performed using
the SPSS statistical package (version 14).
RESULTS
Serum Creatinine and BUN
Serum creatinine (SCr) and BUN were
normal in control group (0.55 ± 0.03 and
17.7 ± 2.07, n = 8). Treatment with
gentamicin for five days induced renal
functional deficiency as demonstrated by
significant increase in SCr and BUN levels
(1.05 ± 0.07 and 49.67 ± 3.97, p<0.001,
Figure 1 and 2). Saffron at doses of 40 mg/
k/d or 80 mg/k/d did not significantly
change serum creatinine (0.54 ± 0.02 or
0.63 ± 0.03, Figure 1) and BUN (17.33 ±
1.706 or 18.83 ± 1.95, Figure 2).
Figure 1: effect of different doses of saffron and gentamicin treatment on serum creatinine
Data are expressed as Mean ± S.E.M for groups of 8 rats each. S40: Saffron 40 mg/k/d, S80:
Saffron 80 mg/k/d, G80: Gentamicin 80 mg/k/d. * p<0.05 in comparison to the control group, **
p<0.01 vs. control group. # p<0.05 in comparison to the G80 treated group, ## p<0. 01 in
comparison to the G80 treated group (One-way ANOVA followed by Post Hoc Tukey test).
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Treatment with saffron 40 mg/k/d for
five days before gentamicin treatment and
five days co-treatment reduced functional
defects revealed by significant decreases in
serum BUN levels (30.67 ± 3.67 p<0.05,
Figure 2), whereas the effects on SCr were
not statistically significant (0.91 ± 0.02,
Figure 1). Moreover, SCr and BUN in the
S40+G80 treated group showed a
significant difference when compared to the
control group (p<0.01 and p<0.05,
respectively, Figure 1 and 2).
Gentamicin-induced nephrotoxicity was
reduced significantly by the saffron 80 mg/
k/d treatment as shown by decreased levels
of SCr and BUN (0.79 ± 0.04, p<0.05 and
24 ± 2.91, p<0.001 respectively, Figure 1
and 2). In addition, SCr in this group was
significantly higher than in the control
group (p<0.05, Figure 1).
Modulation of MDA levels by saffron
extract
Tissue MDA levels increased from 40.7 ±
3.2 in control group to 83.46 ± 8.11 in
gentamicin 80 mg/k/d treated rats (p<0.001,
Figure 3). Saffron at 40 mg/k/d and 80 mg/
k/d did not change tissue MDA levels (46.3
± 3.46 and 41.25 ± 4.01, respectively).
Increased tissue levels of MDA in
gentamicin (80 mg/k/d) treated rats were
reduced by pre and co-treatment with
saffron 80 mg/k/d (55.9 ± 6.5, p<0.05,
Figure 3). In the case of 40 mg/k/d saffron,
this was not significant (77.51 ± 6.76).
Histological evaluation
In the control group, saline treatment failed
to produce histological lesions in the left
kidneys. Treatment with gentamicin 80 mg/
k/d for five days induced moderate to
severe histological damage (p<0.001, Table
1) with dominant tubular necrosis extended
to distal parts of proximal tubules and
epithelial cells dissociation with cast
formation, lose of brush border in large
parts of proximal tubules and tubular
obstruction. In groups of saffron 40 and 80
mg/k/d treated rats there was no sign of
histological changes or cellular necrosis,
whereas both saffron 40 and 80 mg/k/d
reduced gentamicin induced tissue injury
(p<0.05 and p<0.01 respectively, Table 1).
In the S40+G80 treated group necrosis and
epithelial cell damage were restricted to
groups of tubular cells in proximal parts of
Figure 2: effect of different doses of saffron and gentamicin treatment on serum BUN
Data are expressed as Mean ± S.E.M for groups of 8 rats each. S40: Saffron 40 mg/k/d, S80:
Saffron 80 mg/k/d, G80: Gentamicin 80 mg/k/d. * p<0.05 in comparison to the control group, **
p<0.001 in comparison to the control group. # p<0.01 in comparison to the G80 treated group, ##
p<0.001 in comparison to the G80 treated group (One-way ANOVA followed by Post Hoc Tukey
test).
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convoluted tubules (p<0.01 vs. control
group) and in S80+G80 treated rats,
damage was seen only in individual cells in
proximal tubules with preservation of
epithelial cells brush borders (p<0.05 vs.
control group).
DISCUSSION
In our study, administration of gentamicin
80 mg/k/d for five days induced acute renal
failure shown by functional and histological
evidence. Moreover, gentamicin increased
the level of renal tissue MDA production,
which suggested involvement of free
radicals in gentamicin-induced
nephrotoxicity. Our study showed for the
first time that saffron extract can reduce
gentamicin-induced nephrotoxicity and
preserve renal function and histology, and
this effect was dose-dependent and
associated with inhibition of gentamicin
increased tissue MDA levels.
Drug-induced nephrotoxicity is an
important cause of renal failure (Perazella,
2003). Aminoglycosides throughout the
endocytic pathway are taken up into the
epithelial cells of the renal proximal tubules
and stay there for a long time, which leads
to nephrotoxicity. Acidic phospholipids,
broadly distributed in the plasma
membranes in various tissues, were
considered to be the binding site of
aminoglycosides in brush-border membrane
of proximal tubular cells (Nagai and
Takano, 2004; Nagai, 2006). In accordance,
the present study showed a moderate to
severe histological profile in gentamicin
treated group with lost brush borders in
apical parts of tubular epithelial cells that
was dominant in large part of proximal
tubules (Table 1).
It had been shown that gentamicin
treatment causes enhanced generation of
superoxide anion and hydrogen peroxide
(Baliga et al., 1999; Walker et al., 1999)
and accelerates lipid peroxidation in the
renal cortex as reflected by increased MDA,
an end product of lipid peroxidation, and by
depression of poly unsaturated fatty acid
(PUFA), which serve as substrates for free
radical attack (Holub, 1987; Chance et al.,
1979). Gentamicin has been shown to lead
to release of iron from renal cortical
mitochondria and to enhance generation of
hydroxyl radical.  These in vitro
observations have been supported by in
Figure 3: effect of aqueous saffron extract on lipid peroxidation in gentamicin treated rats
MDA levels were measured in 10% homogenates of kidney samples. Values are mean ± SEM
(n=8). S40: Saffron 40 mg/k/d, S80: Saffron 80 mg/k/d, G80: Gentamicin 80 mg/k/d. ** p<0.001 as
compared to the control group, # p<0.05 and ## p<0.01 as compared to the G80 treated group (One-
way ANOVA followed by Post Hoc Tukey test)
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vivo studies in which scavengers of reactive
oxygen metabolites and iron chelators have
shown to be protective in gentamicin
induced acute renal failure (Martínez-
Salgado et al., 2002). In the present work,
along with gentamicin induced renal
functional and histological impairments,
there was a concomitant increase in tissue
MDA levels that was in agreement with
other studies (Holub, 1987; Chance et al.,
1979). This confirms the role of ROS and
lipid peroxidation in gentamicin induced
nephrotoxicity.
In a study designed to approximate a
structure-activity relationship, two
bioactive constituents of saffron extract
were tested, namely crocin and safranal.
Crocin showed high free radical scavenging
activity, followed by safranal. This free
radical scavenging activity may derive from
the ability to donate a hydrogen atom to
free radicals (Assimopoulou et al., 2005).
Purified crocin with purity of >99.6% has
an antioxidative activity at concentrations
up to 40 ppm. At 20 ppm the antioxidative
activity of crocin is comparable to that of
butylated hydroxyanisole (BHA; an
antioxidant is used in cosmetics, drugs and
foods that have unsaturated fatty acids in
their structures) (Pham et al., 2000). In
laying hens following 6 weeks of feeding
with saffron, the rate of lipid oxidation was
determined in refrigerated stored shell eggs
and revealed that MDA levels in saffron
diet groups was less than control group
(Botsoglou et al., 2005). In our study
pretreatment with saffron 80 mg/k/d for
five days followed by co-treatment with
gentamicin 80 mg/k/d, reduced gentamicin
induced high tissue MDA levels (Figure 3).
Related to saffron antioxidant properties
in different experimental evaluations, it has
been shown that pretreatment with crocin
markedly inhibits oxidizing reactions after
global cerebral ischemia (Zheng et al.,
2007) and in hippocampal tissue after
ischemia (Hosseinzadeh and Sadeghnia,
2005). In addition, pretreatment with crocus
sativus (100 mg/k/d) 7 days before the
induction of cerebral ischemia increased the
contents of glutathione (GSH) and its
dependent enzymes, while preventing
elevation of MDA, glutamate and aspartate
contents. All this correlates well with
histopathology by decreasing neuronal cell
death (Saleem et al. ,  2006). Crocin
pretreatment also reduces lipid peroxidation
products, including MDA, and increases
antioxidant capacity in renal ischemia-
reperfusion (Hosseinzadeh et al., 2005).The
results obtained in the present investigation
suggest that saffron extract has an overall
protective effect against gentamicin-
induced nephrotoxicity. The observed
protective effects might be attributed to the
decreased levels of MDA that correlated
with histological and functional data.
TABLE 1
Effects of different doses of saffron on gentamicin - induced nephrotoxicity in rats
Group Treatment Number of each grade observed in each group
0+ 1+ 2+ 3+ 4+
1 Control ### 8 - - - -
2 G80 *** - 1 4 3 -
3 S40 ### 8 - - - -
4 S80 ### 7 1 - - -
5 S40+G80 ** # 1 3 4 - -
6 S80+G80 * ## 2 4 2 - -
Number of each grade observation kidneys prepared from each groups rats after treatment was shown in
columns (n=8). S40: Saffron 40 mg/kg, S80: Saffron 80 mg/kg, G80: Gentamicin 80 mg/kg.
* p<0.05, ** p<0.01 and *** p<0.001 in comparison with control group (Mann-Whitney Test)
# p<0.05, ## p<0.01 and ### p<0.001 in comparison with G80 treated group (Mann-Whitney Test).
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As shown in Figure 3, the effects of
saffron in reducing of MDA levels as an
indicator of lipid peroxidation of renal
tissue was dose dependent. Saffron 40 mg/
k/d did not change MDA levels. This
finding confirms previous studies that
showed a dose dependent effect for saffron
on reducing MDA level (Abdullaev
Jafarova et al., 2002; Botsoglou et al.,
2005), where it has been demonstrated that
the inhibitory effects of saffron against
different malignant cells also was dose
dependent (Abdullaev Jafarova et al.,
2002). Saffron pretreatment for five
consecutive days prior to the administration
of anti-tumor drugs, including cisplatin,
significantly inhibited anti-tumor drug
induced cellular DNA damage (Premkumar
et al., 2006). These findings, together with
other previous results, suggest a potential
role for saffron as an anti-genotoxic, anti-
oxidant (Abdullaev Jafarova et al., 2002)
and chemopreventive agent (Premkumar et
al. ,  2006). A common feature of
cytotoxicity induced by cisplatin and
gentamicin is induction of ROS and lipid
peroxidation (Ramsammy et al., 1985;
Vermeulen and Baldew, 1992; Wachowicz
and Kustro-, 1992; Fauconneau et al.,
1995). In the present study saffron extract
inhibited lipid peroxidation and MDA
production which was in agreement with
findings on cisplatin (Premkumar et al.,
2001; Premkumar et al., 2006).
In conclusion, the present study
demonstrated a potent reno-protective
effect for saffron extract against
gentamicin-induced lipid peroxidation and
nephrotoxicity. Saffron-gentamicin co-
treatment in our study suggests a new
therapeutic strategy, but the precise
mechanisms involved in saffron-induced
renal protection requires further studies.
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